Bank Of New York Mellon Corp Arvinas, Inc. Transaction History

Bank Of New York Mellon Corp

$538 Trillion
Q3 2024

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 09, 2023	BUY	$26.15 - $37.26 $5.33 Million - $7.59 Million	203,659 New	203,659 $5.56 Billion
Q4 2022 Feb 14, 2023	BUY	$32.47 - $57.24 $6.56 Million - $11.6 Million	202,016 New	202,016 $6.91 Million
Q3 2022 Nov 14, 2022	BUY	$41.87 - $57.99 $756,716 - $1.05 Million	18,073 Added 9.77%	203,031 $9.03 Million
Q2 2022 Aug 15, 2022	SELL	$36.01 - $74.24 $69,103 - $142,466	-1,919 Reduced 1.03%	184,958 $7.79 Million
Q1 2022 May 11, 2022	SELL	$60.27 - $81.57 $797,492 - $1.08 Million	-13,232 Reduced 6.61%	186,877 $12.6 Million
Q4 2021 Feb 11, 2022	BUY	$65.85 - $96.21 $139,141 - $203,291	2,113 Added 1.07%	200,109 $16.4 Million
Q3 2021 Nov 12, 2021	BUY	$73.2 - $107.87 $2.42 Million - $3.57 Million	33,055 Added 20.04%	197,996 $16.3 Million
Q2 2021 Aug 11, 2021	BUY	$60.45 - $84.26 $2.26 Million - $3.14 Million	37,310 Added 29.23%	164,941 $12.7 Million
Q1 2021 May 13, 2021	SELL	$58.19 - $91.37 $917,598 - $1.44 Million	-15,769 Reduced 11.0%	127,631 $8.44 Million
Q4 2020 Feb 09, 2021	BUY	$20.19 - $84.93 $862,678 - $3.63 Million	42,728 Added 42.44%	143,400 $12.2 Million
Q3 2020 Nov 12, 2020	BUY	$22.99 - $36.34 $21,702 - $34,304	944 Added 0.95%	100,672 $2.38 Million
Q2 2020 Aug 12, 2020	BUY	$29.88 - $56.74 $603,008 - $1.15 Million	20,181 Added 25.37%	99,728 $3.34 Million
Q1 2020 May 06, 2020	BUY	$33.0 - $54.5 $91,212 - $150,638	2,764 Added 3.6%	79,547 $3.21 Million
Q4 2019 Feb 14, 2020	BUY	$15.39 - $44.38 $291,363 - $840,202	18,932 Added 32.73%	76,783 $3.16 Million
Q3 2019 Nov 07, 2019	BUY	$21.55 - $27.61 $29,006 - $37,163	1,346 Added 2.38%	57,851 $1.25 Million
Q2 2019 Aug 12, 2019	BUY	$15.96 - $23.8 $522,418 - $779,045	32,733 Added 137.7%	56,505 $1.24 Million
Q1 2019 May 14, 2019	BUY	$13.55 - $23.79 $322,110 - $565,535	23,772 New	23,772 $351,000

Others Institutions Holding ARVN

# of Institutions

229

Shares Held

68.4M

Call Options Held

226K

Put Options Held

285K

Vanguard Group Inc Valley Forge, PA

7.01M
Shares

$131 Million
0.0% of portfolio
Eco R1 Capital, LLC San Francisco, CA

6.73M
Shares

$126 Million
7.19% of portfolio
Black Rock Inc. New York, NY

6.26M
Shares

$117 Million
0.0% of portfolio
Price T Rowe Associates Inc Baltimore, MD

3.85M
Shares

$72.2 Million
0.01% of portfolio
Rtw Investments, LP New York, NY

2.78M
Shares

$52.1 Million
1.09% of portfolio

View Full List

About ARVINAS, INC.

Ticker ARVN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 53,205,300
Market Cap $997M
Description
Arvinas, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of therapies to degrade disease-causing proteins. Its lead product candidates include Bavdegalutamide, a proteolysis targeting chimera (PROTAC) protein degrader that is in phase I clinical trial targeting the androgen receptor ...

More about ARVN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of New York Mellon Corp, based on Form 13F filings with the SEC.

News

Stay updated on Bank Of New York Mellon Corp with notifications on news.

Account